Cargando…

In vitro Targeting and Cytotoxicity of Adriamycin in Liposomes Bearing Monoclonal Antibody against Rat or Human gp125 Cell Proliferation‐associated Antigen

Chemoimmunoliposomes (CIL) were prepared by entrapping adriamycin in monoclonal antibody (mAb)‐coated liposomes and examined for their binding capacity and cytotoxicity to relevant target tumor cells. Sonicated unilamellar liposomes were coated with B3 and HBJ127 mouse, mAbs, which recognize a rat a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanaka, Toshiyuki, Suzuki, Shinya, Masuko, Takashi, Hashimoto, Yoshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917737/ https://www.ncbi.nlm.nih.gov/pubmed/2501255 http://dx.doi.org/10.1111/j.1349-7006.1989.tb02323.x

Ejemplares similares

Cytotoxicity of adriamycin to tumour cells in vivo and in vitro.
por: Martin, W. M., et al.
Publicado: (1980)

Antitumor Effect of Liposome‐entrapped Adriamycin Administered via the Portal Vein
por: Ichino, Tatsuo, et al.
Publicado: (1990)

Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin.
por: Gabizon, A., et al.
Publicado: (1991)

Delivery of Lymph Node‐targeted Adriamycin by Gastric Submucosal Liposomal Injection in Rabbits
por: Akamo, Yoshimi, et al.
Publicado: (1993)

Artesunate enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant chronic myeloid leukemia K562/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model.
por: Gabizon, A., et al.
Publicado: (1985)

Antigen presentation by liposomes bearing class II MHC and membrane IL-1.
por: Bakouche, O., et al.
Publicado: (1990)

Release of Esterase from Murine Lymphokine‐activated Killer Cells in Antibody‐dependent Cellular Cytotoxic Reaction
por: Kato, Kazunori, et al.
Publicado: (1991)

Potentiating Effects of MPL on DSPC Bearing Cationic Liposomes Promote Recombinant GP63 Vaccine Efficacy: High Immunogenicity and Protection
por: Mazumder, Saumyabrata, et al.
Publicado: (2011)

TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells
por: Chen, Li, et al.
Publicado: (2019)

Targeting the tumor microenvironment by liposomal Epacadostat in combination with liposomal gp100 vaccine
por: Tahaghoghi-Hajghorbani, Sahar, et al.
Publicado: (2023)

Recognition of a leukemia-related antigen by an antiidiotypic antiserum to an anti-gp70 monoclonal antibody
Publicado: (1985)

Cytotoxicity of anti-c-erbB-2 immunoliposomes containing doxorubicin on human cancer cells.
por: Suzuki, S., et al.
Publicado: (1995)

Cytotoxicity of adriamycin on aerobic and hypoxic chinese hamster V79 cells in vitro.
por: Smith, E., et al.
Publicado: (1980)

Phage Display Cloning and Characterization of Monoclonal Antibody Genes and Recombinant Fab Fragment against the CD98 Oncoprotein
por: Itoh, Kunihiko, et al.
Publicado: (2001)

Chemotherapy Targeting Regional Lymph Nodes by Gastric Submucosal Injection of Liposomal Adriamycin in Patients with Gastric Carcinoma
por: Akamo, Yoshimi, et al.
Publicado: (1994)

Identification of a HIV Gp41-Specific Human Monoclonal Antibody With Potent Antibody-Dependent Cellular Cytotoxicity
por: Yang, Zheng, et al.
Publicado: (2018)

A Murine Monoclonal Antibody that Recognizes an Extracellular Domain of the Human c‐erbB‐2 Protooncogene Product
por: Masuko, Takashi, et al.
Publicado: (1989)

Adriamycin/cyclophosphamide and adriamycin/melphalan in advanced L1210 leukaemia.
por: Tobias, J. S., et al.
Publicado: (1975)

Effect of Circulating Antigen on Immunoscintigraphy of Ovarian Cancer Patients Using Anti‐CA125 Monoclonal Antibody
por: Sakahara, Harumi, et al.
Publicado: (1996)

The monoclonal antibody to cytotoxic T lymphocyte antigen 4, ipilimumab, in the treatment of melanoma
por: Verschraegen, Claire
Publicado: (2012)

Liposome-Mediated Cellular Delivery of Active gp91(phox)
por: Marques, Bruno, et al.
Publicado: (2007)

Inhibition of tumor formation and metastasis by a monoclonal antibody against lymphatic vessel endothelial hyaluronan receptor 1
por: Hara, Yuta, et al.
Publicado: (2018)

Tumour-associated antigens reacting with cytotoxic antibodies in serum of hepatoma-bearing rats.
por: Lando, P., et al.
Publicado: (1981)

Predicting the response of patients with advanced urothelial cancer to methotrexate, vinblastine, Adriamycin, and cisplatin (MVAC) after the failure of gemcitabine and platinum (GP)
por: Kim, Ki Hong, et al.
Publicado: (2015)

Inhibitors of adriamycin-induced histamine release in vitro limit adriamycin cardiotoxicity in vivo.
por: Klugmann, F. B., et al.
Publicado: (1986)

Computational Modulation of the V3 Region of Glycoprotein gp125 of HIV-2
por: Serra, Patrícia A., et al.
Publicado: (2021)

Homotypic Adhesion through Carcinoembryonic Antigen Plays a Role in Hepatic Metastasis Development
por: Yoshioka, Toshiaki, et al.
Publicado: (1998)

Detection of Adriamycin–DNA adducts by accelerator mass spectrometry at clinically relevant Adriamycin concentrations
por: Coldwell, Kate E., et al.
Publicado: (2008)

Identification of Anti-gp41 Monoclonal Antibodies That Effectively Target Cytotoxic Immunoconjugates to Cells Infected with Human Immunodeficiency Virus, Type 1
por: Klug, Grant, et al.
Publicado: (2023)

In vivo tumour-cell proliferation after adriamycin treatment.
por: Rowley, R., et al.
Publicado: (1982)

Effect of cell density on intracellular adriamycin concentration and cytotoxicity in exponential and plateau phase EMT6 cells.
por: Chambers, S. H., et al.
Publicado: (1984)

Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells.
por: Hong, W. S., et al.
Publicado: (1992)

Adriamycin-resistant cells are significantly less fit than adriamycin-sensitive cells in cervical cancer
por: Qi, Min, et al.
Publicado: (2021)

Immunogenicity of liposome-bound hyaluronate in mice. At least two different antigenic sites on hyaluronate are identified by mouse monoclonal antibodies
Publicado: (1988)

Transferrin‐bearing liposomes entrapping plumbagin for targeted cancer therapy
por: Sakpakdeejaroen, Intouch, et al.
Publicado: (2019)

Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer
por: Hong, Woo Sung, et al.
Publicado: (2013)

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96
Publicado: (1995)

Sphingomyelin liposome bearing whole Leishmania lysate antigens induce strong Th2 immune response in BALB/c mice
por: Biari, Nazanin, et al.
Publicado: (2021)

Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM).
por: Raijmakers, R., et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_p34t3drn0efqked1q8nhng6ade